Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
7.68
-0.44 (-5.42%)
Nov 18, 2024, 12:55 PM EST - Market open
Camp4 Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Revenue | 0.35 | 0.35 | - |
| Cost of Revenue | 38.05 | 39.06 | 34.1 |
| Gross Profit | -37.7 | -38.71 | -34.1 |
| Selling, General & Admin | 12.09 | 11.61 | 10.23 |
| Research & Development | 1.56 | 1.56 | 0.68 |
| Operating Expenses | 13.65 | 13.17 | 10.91 |
| Operating Income | -51.35 | -51.88 | -45 |
| Interest & Investment Income | 1.88 | 2.81 | 0.9 |
| Other Non Operating Income (Expenses) | -0.25 | -0.22 | -0.1 |
| Pretax Income | -49.71 | -49.29 | -44.19 |
| Net Income | -49.71 | -49.29 | -44.19 |
| Net Income to Common | -49.71 | -49.29 | -44.19 |
| Shares Outstanding (Basic) | 0 | 0 | 0 |
| Shares Outstanding (Diluted) | 0 | 0 | 0 |
| Shares Change (YoY) | - | 26.47% | - |
| EPS (Basic) | -111.59 | -124.79 | -141.51 |
| EPS (Diluted) | -111.59 | -124.79 | -141.51 |
| Free Cash Flow | -43.55 | -44.83 | -42.57 |
| Free Cash Flow Per Share | -97.75 | -113.51 | -136.31 |
| Operating Margin | -14671.43% | -14822.57% | - |
| Profit Margin | -14203.71% | -14083.14% | - |
| Free Cash Flow Margin | -12441.71% | -12809.43% | - |
| EBITDA | -49.63 | -50.2 | -44.12 |
| D&A For EBITDA | 1.73 | 1.68 | 0.88 |
| EBIT | -51.35 | -51.88 | -45 |
Source: S&P Capital IQ. Standard template.
Financial Sources.